Literature DB >> 6630526

Sources and quantity of 3,5,3'-triiodothyronine in several tissues of the rat.

J van Doorn, D van der Heide, F Roelfsema.   

Abstract

The local conversion of thyroxine (T4), which is an important source of intracellular 3,5,3'-triiodothyronine (T3) in several rat tissues, has been subject of recent investigations. In the present study the regulation of this phenomenon in vivo was investigated in various peripheral tissues of the rat. Intact euthyroid and radiothyroidectomized (Tx) rats received a continuous intravenous infusion of [125I]T4 and [131I]T3 until isotope equilibrium was attained. In addition to the labeled iodothyronines, Tx rats received a continuous intravenous infusion of 0.2 or 1.0 microgram carrier T4/100 g body wt per d, to create hypothyroid or slightly hypothyroid conditions, respectively. After the animals were bled and perfused the contribution of T3 derived from local conversion of T4 to T3 [Lc T3(T4)] to the total T3 in homogenates from several tissues and subcellular fractions from the liver, kidney, and anterior pituitary gland could be calculated. In all experiments T3 in muscle was derived exclusively from the plasma. In the cerebral cortex and cerebellum, however, most of the intracellular T3 was derived from the intracellular conversion of T4 to T3. It is demonstrated that for hypothyroid rats an increased relative contribution of Lc T3(T4) reduced the loss of total T3 in the brain. This phenomenon was also encountered for the anterior pituitary gland, although in this tissue the proportion of the total tissue T3, contributed by locally produced T3 was considerably lower than the values found for the cerebral cortex and cerebellum in all experiments. The present findings, regarding the source and quantity of pituitary nuclear T3 strongly suggest that both plasma T3 and T4 (through its local conversion into T3) play a role in the regulation of thyrotropin secretion. The contribution of Lc T3(T4) to the total pituitary nuclear T3 was of minor importance in euthyroid rats (approximately 20%), compared with that found for both groups in T4-supplemented athyreotic rats (approximately 40%). The total T3 concentration in the liver decreased from euthyroid to hypothyroid rats and was associated with a decrease in the tissue/plasma T3 concentration gradient. A minor proportion of hepatic T3 was contributed by Lc T3(T4), which in fact decreased significantly from the euthyroid to the hypothyroid state. In contrast to other subcellular fractions from the liver, no Lc T3(T4) could be demonstrated in the nuclear fraction. It is suggested that the liver plays an important role with respect to regulation of the circulating T3 concentration. In the kidney, a very small proportion of the total T3 was derived from locally produced T3 in all experiments (4-7%). As found in the liver, all nuclear T3 appeared to be derived from the plasma. In contrast to the liver, subcellular T3 pools in the kidney seemed to be exchangeable.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6630526      PMCID: PMC370467          DOI: 10.1172/JCI111138

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  Subcellular localization of a rat liver enzyme converting thyroxine into tri-iodothyronine and possible involvement of essential thiol groups.

Authors:  T J Visser; I Does-Tobé; R Docter; G Hennemann
Journal:  Biochem J       Date:  1976-08-01       Impact factor: 3.857

Review 2.  Nuclear receptors and the initiation of thyroid hormone action.

Authors:  J H Oppenheimer; H L Schwartz; M I Surks; D Koerner; W H Dillmann
Journal:  Recent Prog Horm Res       Date:  1976

3.  Synthesis of 125I monolabelled 3, 5, 3'-triiodothyronine and thyroxine of maximum specific activity for radioimmunoassay.

Authors:  J Weeke; H Orskov
Journal:  Scand J Clin Lab Invest       Date:  1973-12       Impact factor: 1.713

4.  Enzyme localization in the inner and outer membranes of rat liver mitochondria.

Authors:  D S Beattie
Journal:  Biochem Biophys Res Commun       Date:  1968-06-28       Impact factor: 3.575

5.  Binding of T3 in rat liver nuclei.

Authors:  L J DeGroot; J L Strausser
Journal:  Endocrinology       Date:  1974-07       Impact factor: 4.736

6.  An improved method for chromatography of iodothyronines.

Authors:  D Bellabarba; R E Peterson; K Sterling
Journal:  J Clin Endocrinol Metab       Date:  1968-02       Impact factor: 5.958

7.  The extrathyroidal conversion rate of thyroxine to triiodothyronine in normal man.

Authors:  C S Pittman; J B Chambers; V H Read
Journal:  J Clin Invest       Date:  1971-06       Impact factor: 14.808

8.  Improvements in the ethidium bromide method for direct fluorometric estimation of DNA and RNA in cell and tissue homogenates.

Authors:  U Karsten; A Wollenberger
Journal:  Anal Biochem       Date:  1977-02       Impact factor: 3.365

9.  Production and storage of (125-I) thyroxine and (125-I) triiodothyronine of high specific activity.

Authors:  J M Kjeld; S F Kuku; L Diamant; T R Fraser; G F Joplin; K Mashiter
Journal:  Clin Chim Acta       Date:  1975-06-20       Impact factor: 3.786

10.  Quantitation of extrathyroidal conversion of L-thyroxine to 3,5,3'-triiodo-L-thyronine in the rat.

Authors:  H L Schwartz; M I Surks; J H Oppenheimer
Journal:  J Clin Invest       Date:  1971-05       Impact factor: 14.808

View more
  13 in total

1.  Role of sodium in thyroid hormone uptake by rat skeletal muscle.

Authors:  M Centanni; J Robbins
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

2.  Effects of substitution and high-dose thyroid hormone therapy on deiodination, sulfoconjugation, and tissue thyroid hormone levels in prolonged critically ill rabbits.

Authors:  Yves Debaveye; Björn Ellger; Liese Mebis; Theo J Visser; Veerle M Darras; Greet Van den Berghe
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

3.  Comparative study of pituitary-thyroid hormone economy in fasting and hypothyroid rats.

Authors:  D L St Germain; V A Galton
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

4.  Congenital hypothyroidism, as studied in rats. Crucial role of maternal thyroxine but not of 3,5,3'-triiodothyronine in the protection of the fetal brain.

Authors:  R Calvo; M J Obregón; C Ruiz de Oña; F Escobar del Rey; G Morreale de Escobar
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

5.  Replacement therapy for hypothyroidism with thyroxine alone does not ensure euthyroidism in all tissues, as studied in thyroidectomized rats.

Authors:  H F Escobar-Morreale; M J Obregón; F Escobar del Rey; G Morreale de Escobar
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

6.  Type II iodothyronine deiodinase provides intracellular 3,5,3'-triiodothyronine to normal and regenerating mouse skeletal muscle.

Authors:  Alessandro Marsili; Dan Tang; John W Harney; Prabhat Singh; Ann Marie Zavacki; Monica Dentice; Domenico Salvatore; P Reed Larsen
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-07-19       Impact factor: 4.310

7.  Thyroid hormones in tissues from human embryos and fetuses.

Authors:  A Costa; R Arisio; C Benedetto; E Bertino; C Fabris; G Giraudi; L Marozio; V Maulà; M Pagliano; O Testori
Journal:  J Endocrinol Invest       Date:  1991 Jul-Aug       Impact factor: 4.256

8.  Role of L-thyroxine in nuclear thyroid hormone receptor occupancy and growth hormone production in cultured GC cells.

Authors:  Y Halperin; L E Shapiro; M I Surks
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

9.  Iodothyronine deiodinase activity in methionine-deficient rats fed selenium-deficient or selenium-sufficient diets.

Authors:  Z Zhu; M Kimura; Y Itokawa
Journal:  Biol Trace Elem Res       Date:  1995-05       Impact factor: 3.738

10.  Production rates and turnover of triiodothyronine in rat-developing cerebral cortex and cerebellum. Responses to hypothyroidism.

Authors:  J E Silva; P S Matthews
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.